Tristel
Organization
A UK healthcare company developing infection-prevention and decontamination products, particularly for medical instruments and clinical environments.
What experts have said about Tristel
3 statements · 2 negative · 1 mixed
Tristel’s valuation is demanding at roughly thirty times forecast earnings.
“The shares are trading at, I don't know, about 30-odd times forecast earnings. So it's quite a punchy rating.”
Open the episode · IC028 UK investors Insights Covering Alphabet, Nestle, Unilever, Tristel, Nichols, Nexteq, LBG Media, Ryanair, EasyJet & FRP Advisory Group.Listen at 24:33
Tristel’s demanding valuation depends on continued US growth.
“It just looks really demanding to us, but potentially it's justified. But it all depends on that US growth.”
Open the episode · IC028 UK investors Insights Covering Alphabet, Nestle, Unilever, Tristel, Nichols, Nexteq, LBG Media, Ryanair, EasyJet & FRP Advisory Group.Listen at 26:18
Tristel shares have a high valuation.
“It's very highly rated.”
Open the episode · IC023 Investor Insights: Private Equity Trends, Contrasting Founders, Good Results & Investment IdeasListen at 24:01
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
2 episodes featuring Tristel
Investor's Champion Podcast
Investors test tech giants against durable brands and small caps
The episode shows how investors weigh valuation, cash generation and execution across businesses facing very different risks.
Jul 27, 2024 · 29 min
Investor's Champion Podcast
Private equity reshapes UK markets as investors test company quality
The episode connects private funding, shrinking public markets and higher rates with a practical test of valuation, debt and accounting quality.
Jun 22, 2024 · 35 min